CHARGE syndrome: A review of the immunological aspects

European Journal of Human Genetics

Volumn 23, Issue 11, 2015, Pages 1451-1459

  Wong, Monica T Y ^a   Schölvinck, Elisabeth H ^a   Lambeck, Annechien J A ^a   Van Ravenswaaij Arts, Conny M A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; CHD7 PROTEIN, HUMAN; DNA BINDING PROTEIN; DNA HELICASE;

ACROCEPHALOSYNDACTYLY; ALAGILLE SYNDROME; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONGENITAL MALFORMATION; CONJUNCTIVITIS; DERMATITIS; HUMAN; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOLOGY; KABUKI MAKEUP SYNDROME; LYMPHOCYTOPENIA; NATURAL KILLER CELL; NONHUMAN; OMENN SYNDROME; OTITIS MEDIA; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT INFECTION; REVIEW; SEPSIS; SEPTIC SHOCK; SINUSITIS; SYNDROME CHARGE; SYSTEMATIC REVIEW; THRUSH; DIGEORGE SYNDROME; FEMALE; GENETICS; HAPLOINSUFFICIENCY; IMMUNOLOGY; PATHOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

CHARGE SYNDROME; DIGEORGE SYNDROME; DNA HELICASES; DNA-BINDING PROTEINS; FEMALE; HAPLOINSUFFICIENCY; HUMANS; PREGNANCY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84944354045     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.7     Document Type: Review

References (75)

1. Angelman H. Syndrome of coloboma with multiple congenital abnormalities in infancy. Br Med J. 1961; 1: 1212-1214.
2. Edwards JH, Finlay HVL, Young RB. Coloboma with Multiple Congenital Anomalies. Br Med J. 1961; 2: 586-587.
3. Hall BD. Choanal atresia and associated multiple anomalies. J Pediatr. 1979; 95: 395-398.
4. Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation-A syndrome. J Pediatr Ophthalmol Strabismus. 1979; 16: 122-128.
5. Pagon RA, Graham JMJr, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr. 1981; 99: 223-227.
6. Janssen N, Bergman JE, Swertz MA, et al. Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat. 2012; 33: 1149-1160.
7. BlakeKD, Davenport SL, HallBDet al. CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) 1998; 37: 159-173.
8. Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am J Med Genet A. 2005; 133: 306-308.
9. Jongmans MC, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006; 43: 306-314.
10. Lalani SR, Safiullah AM, Fernbach SD, et al. Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006; 78: 303-314.
11. Vissers LE, van Ravenswaaij CM, Admiraal R, et al. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet. 2004; 36: 955-957.
12. Bergman JE, Janssen N, van der Sloot AM, et al. A novel classification system to predict the pathogenic effects of CHD7 missense variants in CHARGE syndrome. Hum Mutat. 2012; 33: 1251-1260.
13. Bergman JE, Janssen N, Hoefsloot LH, Jongmans MC, Hofstra RM, van Ravenswaaij-Arts CM. CHD7 mutations and CHARGE syndrome: the clinical implications of an expanding phenotype. J Med Genet. 2011; 48: 334-342.
14. Jyonouchi S, McDonald-Mcginn DM, Bale S, Zackai EH, Sullivan KE. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics. 2009; 123: e871-e877.
15. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997; 130: 388-393.
16. North KN, Wu BL, Cao BN, Whiteman DA, Korf BR. CHARGE association in a child with de novo inverted duplication (14)(q22-4q24.3). Am J Med Genet. 1995; 57: 610-614.
17. Theodoropoulos DS. Immune deficiency in CHARGE association. Clin Med Res. 2003; 1: 43-48.
18. Kaliakatsos M, Giannakopoulos A, Fryssira H, et al. Combined microdeletions and CHD7 mutation causing severe CHARGE/DiGeorge syndrome: clinical presentation and molecular investigation by array-CGH. J Hum Genet. 2010; 55: 761-763.
19. Lonlay-Debeney P, Cormier-Daire V, Amiel J, et al. Features of DiGeorge syndrome and CHARGE association in five patients. J Med Genet. 1997; 34: 986-989.
20. Markert ML, Alexieff MJ, Li J, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 2004; 104: 2574-2581.
21. Markert ML, Alexieff MJ, Li J, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol. 2004; 113: 734-741.
22. Janda A, Sedlacek P, Mejstrikova E, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007; 11: 441-447.
23. Gennery AR, Slatter MA, Rice J, et al. Mutations in CHD7 in patients with CHARGE syndrome cause T-B+natural killer cell+severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol. 2008; 153: 75-80.
24. Boudny P, Kurrer MO, Stamm B, Laeng RH. Malakoplakia of the colon in an infant with severe combined immunodeficiency (SCID) and charge association. Pathol Res Pract. 2000; 196: 577-582.
25. Wood DJ, David TJ, Chrystie IL, Totterdell B. Chronic enteric virus infection in two T-cell immunodeficient children. J Med Virol. 1988; 24: 435-444.
26. Markert ML, Boeck A, Hale LP, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med. 1999; 341: 1180-1189.
27. Markert ML, Sarzotti M, Ozaki DA, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 2003; 102: 1121-1130.
28. Rice HE, Skinner MA, Mahaffey SM, et al. Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg. 2004; 39: 1607-1615.
29. Writzl K, Cale CM, Pierce CM, Wilson LC, Hennekam RC. Immunological abnormalities in CHARGE syndrome. Eur J Med Genet. 2007; 50: 338-345.
30. Sanka M, Tangsinmankong N, Loscalzo M, Sleasman JW, Dorsey MJ. Complete DiGeorge syndrome associated with CHD7 mutation. J Allergy Clin Immunol. 2007; 120: 952-954.
31. Hoover-Fong J, Savage WJ, Lisi E, et al. Congenital T cell deficiency in a patient with CHARGE syndrome. J Pediatr. 2009; 154: 140-142.
32. Chopra C, Baretto R, Duddridge M, Browning MJ: T-cell immunodeficiency in CHARGE syndrome. Acta Paediatr. 2008; 98: 408-412.
33. Inoue H, Takada H, Kusuda T, et al. Successful cord blood transplantation for a CHARGE syndrome with CHD7 mutation showing DiGeorge sequence including hypoparathyroidism. Eur J Pediatr. 2010; 169: 839-844.
34. Assing K, Nielsen C, Kirchhoff M, Madsen HO, Ryder LP, Fisker N. CD4 CD31 recent thymic emigrants in CHD7 haploinsufficiency (CHARGE syndrome): A case. Hum Immunol. 2013; 74: 1047-1050.
35. Markert ML, Majure M, Harville TO, Hulka G, Oldham K. Severe laryngomalacia and bronchomalacia in DiGeorge syndrome and CHARGE association. Pediatr Pulmonol. 1997; 24: 364-369.
36. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr. 1998; 132: 15-21.
37. Squires LA, Dieffenbach AZ, Betz BW. Three malformation complexes related to neural crest development. Brain Dev. 1998; 20: 183-185.
38. Lee KD, Okazaki T, Kato Y, Lane GJ, Yamataka A. Esophageal atresia and tracheo-esophageal fistula associated with coarctation of the aorta, CHARGE association, and DiGeorge syndrome: a case report and literature review. Pediatr Surg Int. 2008; 24: 1153-1156.
39. Corsten-Janssen N, Saitta SC, Hoefsloot LH, et al. More clinical overlap between 22q11.2 deletion syndrome and CHARGE syndrome than often anticipated. Mol Syndromol. 2012; 4: 235-245.
40. Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci. 2012; 69: 17-27.
41. McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90: 1-18.
42. Finocchi A, Di Cesare S, Romiti ML, et al. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol. 2006; 17: 382-388.
43. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002; 86: 422-425.
44. Patel K, Akhter J, Kobrynski L, et al. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr. 2012; 161: 950-953.
45. Björk AH, Oskarsdottir S, Andersson BA, Friman V. Antibody deficiency in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2012; 158A: 1934-1940.
46. Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001; 139: 715-723.
47. McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol. 2007; 66: 1-7.
48. Quiros-Tejeira RE, Ament ME, Heyman MB, et al. Variable morbidity in alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr. 1999; 29: 431-437.
49. Le Friec G, Sheppard D, Whiteman P, et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat Immunol. 2012; 13: 1213-1221.
50. Scheuerle AE, Good RA, Habal MB. Involvement of the thymus and cellular immune system in craniofacial malformation syndromes. J Craniofac Surg. 1990; 1: 88-90.
51. Niikawa N, Kuroki Y, Kajii T, et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet. 1988; 31: 565-589.
52. Schulz Y, Freese L, Manz J, et al. CHARGE and Kabuki syndromes: A phenotypic and molecular link. Hum Mol Genet. 2014; 23: 4396-4405.
53. Hoffman JD, Ciprero KL, Sullivan KE, et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet A. 2005; 135: 278-281.
54. Chrzanowska KH, Krajewska-Walasek M, Kus J, et al. Kabuki (Niikawa-Kuroki) syndrome associated with immunodeficiency. Clin Genet. 1998; 53: 308-312.
55. Ming JE, Russell KL, McDonald-McGinn DM, Zackai EH. Autoimmune disorders in Kabuki syndrome. Am J Med Genet A. 2005; 132A: 260-262.
56. Randall V, McCue K, Roberts C, et al. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest. 2009; 119: 3301-3310.
57. Hurd EA, Poucher HK, Cheng K, Raphael Y, Martin DM. The ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural gene expression and neurogenesis in the inner ear. Development. 2010; 137: 3139-3150.
58. van Bueren KL, Papangeli I, Rochais F, et al. Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Dev Biol. 2010; 340: 369-380.
59. Aramaki M, Kimura T, Udaka T, et al. Embryonic expression profile of chicken CHD7, the ortholog of the causative gene for CHARGE syndrome. Birth Defects Res A Clin Mol Teratol. 2007; 79: 50-57.
60. Sanlaville D, Etchevers HC, Gonzales M, et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet. 2006; 43: 211-217.
61. Poliani PL, Facchetti F, Ravanini M, et al. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood. 2009; 114: 105-108.
62. Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol. 2007; 7: 64-75.
63. Dongre A, Surampudi L, Lawlor RG, et al. Non-canonical Notch signaling drives activation and differentiation of peripheral CD4(+) T cells. Front Immunol. 2014; 5: 54.
64. Palacios R, Goni J, Martinez-Forero I, et al. A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases. PLoS One. 2007; 2: e1222.
65. Campese AF, Grazioli P, de Cesaris P, et al. Mouse sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1. Biol Reprod. 2014; 90: 53.
66. Engelen E, Akinci U, Bryne JC, et al. Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet. 2011; 43: 607-611.
67. Numakura C, Kitanaka S, Kato M, et al. Supernumerary impacted teeth in a patient with SOX2 anophthalmia syndrome. Am J Med Genet A. 2010; 152A: 2355-2359.
68. Jongmans MC, Ravenswaaij-Arts CM, Pitteloud N, et al. CHD7 mutations in patients initially diagnosed with Kallmann syndrome-The clinical overlap with CHARGE syndrome. Clin Genet. 2009; 75: 65-71.
69. Layman WS, Hurd EA, Martin DM. Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. Hum Mol Genet. 2011; 20: 3138-3150.
70. Yu T, Meiners LC, Danielsen K, et al. Deregulated FGF and homeotic gene expression underlies cerebellar vermis hypoplasia in CHARGE syndrome. Elife. 2013; 2: e01305.
71. Byrd VM, Kilkenny DM, Dikov MM, et al. Fibroblast growth factor receptor-1 interacts with the T-cell receptor signalling pathway. Immunol Cell Biol. 2003; 81: 440-450.
72. Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010; 152A: 674-686.
73. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE: T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood. 2004; 103: 1020-1025.
74. Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol. 2010; 135: 236-246.
75. Wincent J, Holmberg E, Strömland K, et al. CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. Clin Genet. 2008; 74: 31-38.